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Abstract We have molecularly cloned TPP36, a novel 36 kDa
protein with 281 amino acids that was identi¢ed as a protein
phosphorylated in B progenitor cells following stimulation with
pervanadate/H2O2. Analysis with anti-TPP36 antiserum re-
vealed that TPP36 was expressed ubiquitously and had an iso-
form with 236 amino acids, designated TPP32. TPP36/32 were
localized mainly in cytoplasm despite the presence of a typical
nuclear localization signal sequence. These proteins were phos-
phorylated preferentially by Abl among a panel of tyrosine ki-
nases examined. Phosphorylation of tyrosine 120 in TPP36/32
led to an apparent mobility shift in sodium dodecyl sulfate^poly-
acrylamide gel electrophoresis, suggesting conformational
change in the phosphorylated protein. Thus, TPP36/32 appear
to be novel substrates of Abl tyrosine kinase.
. 2003 Published by Elsevier Science B.V. on behalf of the
Federation of European Biochemical Societies.
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1. Introduction
B cells, precursors of antibody secreting cells, originate
from pluripotent hematopoietic stem cells and di¡erentiate
in the bone marrow. Proliferation and di¡erentiation of
B precursor cells are governed by signaling through various re-
ceptors expressed on their surface, including the IL-7 receptor
and the preB cell receptor [1,2]. Ample evidence suggests that
an array of both tyrosine and serine/threonine protein kinases
is involved in the signal transduction for the di¡erentiation of
lymphocyte precursors and the activation of mature lympho-
cytes [3,4]. However, the identities of protein kinases and their
substrates involved in early B cell development have not been
fully elucidated.
Treatment of living cells with pervanadate/H2O2 inhibits
protein tyrosine phosphatases, thereby modifying the intracel-
lular equilibrium between dephosphorylation and phosphory-
lation [5,6]. Previous studies showed that treatment of mature
B cell lines with pervanadate/H2O2 induces the strong phos-
phorylation of a subset of intracellular proteins similar to that
observed following antigen stimulation of the B cell receptor
(BCR) [7]. In contrast, BCR-de¢cient B cell lines display only
a weak substrate phosphorylation even following stimulation
with pervanadate/H2O2. These data indicate that certain sig-
naling components including protein tyrosine kinases (PTKs)
are already associated with unligated BCR and constitute a
preformed BCR-associated transducer complex [8]. Indeed,
analysis of tyrosine phosphorylated proteins in pervanadate/
H2O2-treated B cells led to the identi¢cation and cloning of
SLP-65 (SH2 domain-containing leukocyte protein of 65, also
called BLNK (B cell linker protein) and BASH (B cell adaptor
containing src homology 2 domain)), an adapter protein es-
sential for BCR signal transduction [9].
We have tried to identify possible substrates of PTKs
involved in early B cell development by stimulating early
B precursor cells with pervanadate/H2O2. In this process we
have identi¢ed a novel protein with two isoforms, designated
TPP36 and TPP32, that are phosphorylated by the tyrosine
kinase Abl and evolutionarily conserved between various spe-
cies. Mice de¢cient for c-Abl and those expressing constitu-
tively active Abl showed altered di¡erentiation and prolifera-
tion of progenitor B cells, suggesting the involvement of Abl
in normal B cell development [10^12]. We report here the
molecular cloning and biochemical characterization of
TPP36/32 and discuss their possible roles in vivo.
2. Materials and methods
2.1. Cell lines and culture conditions
All media used to culture cell lines were supplemented with 10%
fetal calf serum (FCS), 100 U/ml of penicillin-streptomycin, 2 mM
L-glutamine, and 50 WM 2-mercaptoethanol: IMDM medium for
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proB cell line 63-12 [13]; RPMI 1640 medium for Cos7 cells, and
DMEM medium for 293T and ST2 cells [14]. TonB.210.1 cells [15]
carrying a tetracycline-inducible Bcr-Abl p210 gene were maintained
in supplemented RPMI 1640 containing 10% medium conditioned by
WEHI 3B cells (as an IL3 source), Bcr-Abl expression was induced by
adding 1 Wg/ml doxycyclin (Sigma, St. Louis, MO, USA) to the cul-
ture medium. To inhibit Bcr-Abl kinase activity, 10 WM STI-571 (No-
vartis Pharma, Basel, Switzerland) was added to the culture medium.
2.2. Antibodies
Antibodies speci¢c to Syk, Btk (Bruton’s tyrosine kinase), c-Abl
were purchased from Santa Cruz Biotech. (Santa Cruz, CA, USA).
Biotin- or agarose-conjugated anti-phosphotyrosine mAb (4G10),
anti-Lyn and anti-c-Src antibodies were purchased from Upstate Bio-
tech. (Lake Placid, NY, USA). Anti-FLAG M2 mAb was purchased
from Sigma. Antiserum against TPP36 was generated by immunizing
rabbits with recombinant TPP36 protein produced in Escherichia coli.
2.3. Puri¢cation and cDNA cloning of TPP36
63-12 cells (1012) were stimulated at 108/ml in 5% FCS/PBS (phos-
phate-bu¡ered saline) with 0.2 mM pervanadate/H2O2 for 5 min at
37‡C, washed with cold inhibition bu¡er (10 mM Tris^HCl (pH 7.5),
150 mM NaCl, 1 mM ethylene glycol-bis(2-aminoethyl-ether)-
N,N,NP,NP-tetraacetic acid, 1.5 mM MgCl2, 100 mM NaF, 1 mM
Na3VO4, 1 Wg/ml aprotinin, 1 Wg/ml leupeptin, 10 Wg/ml soybean
trypsin inhibitor, 1Wg/ml anti-K-trypsin) and then lysed with 1%
NP-40 containing inhibition bu¡er. Proteins with molecular weight
of 30^40 kDa were enriched from the lysates by using Prep Cell
(Bio-Rad Laboratories, Hercules, CA, USA) and DEAE^Sepharose.
The isolated proteins were dialyzed against bu¡er A (20 mM Tris^
HCl (pH 7.4), 10 mM ethylenediamine tetraacetic acid, 100 mM
NaCl, 0.2 mM Na3VO4, 0.01% NaN3) and loaded onto 4G10-con-
jugated Sepharose. Tyrosine-phosphorylated proteins were eluted with
bu¡er A containing 10 mM phenyl phosphate. Finally, TPP36 was
isolated from eluted proteins with phenyl-5-PW (reverse phase chro-
matography), separated by sodium dodecyl sulfate^polyacrylamide gel
electrophoresis (SDS^PAGE) and stained with Coomassie brilliant
blue. The TPP36 band was excised and subjected to in-gel digestion
with lysyl endopeptidase, and the resulting peptides were puri¢ed by
high-performance liquid chromatography and sequenced by electro-
spray ionization tandem mass spectrometry. Two overlapping clones
in the mouse EST (expressed sequence tag) database (GenBank acces-
sion nos. L22067 and AA842053) were found to encode the three
sequenced peptides from TPP36. A Vgt11 cDNA library prepared
from 63-12 proB cell line was screened with the cDNA fragments
corresponding to these two clones, and obtained cDNAs were se-
quenced.
2.4. Plasmid constructs
The cDNAs coding for wild-type and mutant TPP36/32 were modi-
¢ed to add FLAG epitope at the N- or C-terminus of TPP36 and
subcloned into BCMGS [16] for stable transfection or into pCAGGS
[17] for transient transfection. pME vectors carrying Syk and Lyn
cDNA [18], pcDNA3-carrying Bcr-Abl cDNA [15], pcDNA3-carrying
c-Src and dominant active (DA) Src cDNA[19] and pME18S [20]
carrying mouse Btk cDNA were described previously.
2.5. DNA transfection
63-12 cells (5U106) were resuspended in 500 Wl of K-PBS (NaCl
30.8 mM, KCl 120.7 mM, Na2HPO4 8.1 mM, KH2PO4 1.46 mM)
with 5 mM MgCl2 and electroporated at 330 V, 960 WF using Gene
Pulsar II (Bio-Rad). To select for stably transfected cells, 2 mg/ml of
hygromycin was added to culture medium 48 h after electroporation.
Transient transfection of Cos7 and 293T cells was performed using a
mammalian transfection kit (Stratagene, La Jolla, CA, USA) accord-
ing to the manufacturer’s instructions.
2.6. Immunoprecipitation and immunoblot analysis
Cells were collected by centrifugation and then lysed with inhibition
bu¡er containing 1% NP-40. Cell lysates were incubated with anti-
bodies at 4‡C for 1 h followed by incubation with 20 Wl of Protein A^
Sepharose beads (Amersham Pharmacia, Buckinghamshire, UK) for
30 min. The immunoprecipitates were resolved on SDS^PAGE, trans-
ferred to polyvinylidene di£uoride membrane, and then immunoblot-
ted with antibodies described above. After reaction with horseradish
peroxidase-conjugated second antibodies (Santa Cruz Biotech.), pro-
teins were visualized by an enhanced chemiluminescence system
(Amersham Pharmacia).
2.7. Immuno£uorescence
Cells were ¢xed with 3.7% formaldehyde/PBS for 10 min, permea-
bilized with 0.2% Triton X-100/PBS for 15 min, and then blocked
with 3% bovine serum albumin (BSA)/PBS for 30 min. To detect
exogenous or endogenous TPP36/32, cells were incubated with anti-
FLAG mAb or anti-TPP36 antiserum for 30 min and then with £uo-
rescein isothiocyanate (FITC)-conjugated anti-mouse FcQ antibodies
(Jackson Immunoresearch Laboratories, West Grove, PA, USA) or
FITC-conjugated goat anti-rabbit IgG (Cappel Organon Teknika,
Durham, NC, USA). Stained cells were analyzed by confocal micros-
copy using a 3D projection image analyzer (Leica TCS NT, Heidel-
berg, Germany).
3. Results
3.1. Puri¢cation and molecular cloning of TPP36
To identify possible substrates of PTKs involved in early
Fig. 1. Puri¢cation and cDNA cloning of TPP36. A: 63-12 cells
were treated with pervanadate/H2O2 at 37‡C for 5 min. Cell lysates
were prepared and incubated with anti-phosphotyrosine (4G10)-con-
jugated beads. The immunoprecipitates were analyzed by 2D (IEF/
SDS^PAGE) gel electrophoresis, followed by immunoblot with
4G10. Arrowhead indicates the spots representing TPP36. B: Coo-
massie brilliant blue staining of the puri¢ed TPP36 in a SDS^PAGE
gel as indicated by the arrow. C: The predicted amino acid se-
quence of mouse TPP36 has been aligned with those of its homo-
logs in the indicated species. Three underlines indicate peptide se-
quences determined by tandem mass spectrum from puri¢ed TPP36
protein. The dots indicate potential tyrosine-phosphorylation sites.
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B cell development, proB cell line 63-12 was stimulated with
pervanadate/H2O2. Tyrosine-phosphorylated proteins were
separated in 2D gel and detected with anti-phosphotyrosine
antibody 4G10 (Fig. 1A). We focused our e¡orts on a protein
with an apparent molecular weight of 36 kDa and a pI of 5.6^
5.7. Immunoblot analysis revealed that this protein was dis-
tinct from IgK and IgL (data not shown), both of which have
been shown to be tyrosine-phosphorylated in B cell lineages
following BCR or preBCR stimulation [21]. The protein,
which we called tyrosine-phosphorylated protein 36 (TPP36),
was puri¢ed from 1012 pervanadate-stimulated 63-12 cells by a
series of puri¢cation procedures including a⁄nity chromatog-
raphy with 4G10 (Fig. 1B). Three stretches of partial amino
acid sequences of the puri¢ed protein were obtained from
tandem mass spectrometry of lysyl endopeptidase-digested
peptides (Fig. 1C, underlined sequences). Four clones in the
mouse DNA database (GenBank accession nos. L22067,
AA824053, AF215660 and AF320340) were found to encode
all or a part of the three sequenced peptides. Polymerase chain
reaction (PCR) products corresponding to these clones were
used to isolate a cDNA clone from a Vgt11 cDNA library
prepared from the 63-12 proB cell line. Sequencing of this
cDNA (GenBank accession no. AB046372) revealed that it
was identical to cDNA clone CDV-3B (carnitine de¢ciency-
associated gene expressed in ventricle; GenBank accession no.
AF320340), which was recently reported as a gene up-regu-
lated in the hypertrophied ventricles of carnitine-de¢cient
mice [22]. No biochemical characterization and functional
analysis of the CDV-3B gene product has been reported.
The cDNA encoded an open reading frame corresponding
to a 281 amino acid polypeptide including six tyrosine resi-
dues that are putative targets for phosphorylation. The
N-terminal portion of the protein contained a short stretch
of basic lysine residues (KKKKK) followed by a region rich
in Gly and Ser. The central part of the protein is rich in Pro,
including three PXXP motifs. The analysis of the puri¢ed
protein with tandem mass spectrometry revealed that the ala-
Fig. 2. FLAG-tagged TPP36 was expressed in 63-12 cells as a 37
kDa protein and tyrosine-phosphorylated upon stimulation with
pervanadate/H2O2. A: 63-12 cells were stably transfected with
FLAG-TPP36 cDNA or control vector. Cell lysates were incubated
with anti-FLAG Ab, and the immunoprecipitates were subjected to
SDS^PAGE, followed by immunoblot analysis with anti-FLAG Ab.
The arrow indicates the FLAG-TPP36 protein. B: 63-12 cells stably
transfected with FLAG-TPP36 cDNA were stimulated with 0.2 mM
pervanadate/H2O2 at 37‡C for 5 min. Cell lysates were incubated
with anti-FLAG Ab, and the immunoprecipitates were subjected to
SDS^PAGE, followed by immunoblot analysis with 4G10 or anti-
FLAG Ab.
Fig. 3. Analysis with anti-TPP36 antiserum revealed the ubiquitous
expression of TPP36 and the presence of its isoform TPP32.
A: Cos7 cells were transiently transfected with FLAG-TPP36
cDNA. FLAG-TPP36 proteins were immunoprecipitated with anti-
FLAG Ab and subjected to SDS^PAGE followed by immunoblot
analysis with anti-TPP36 antiserum, pre-immune serum as a control
or anti-FLAG antibody. B,C: Expression of TPP36 protein was ex-
amined in a panel of B lineage cell lines (panel B) and in various
tissues (panel C) by immunoprecipitation and immunoblot with
anti-TPP36 antiserum. The arrows indicate the TPP36 protein.
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nine residue at position 2 was acetylated. A search of the
GenBank database revealed that homologs of the mouse
CDV-3B gene exist in many species, including mammals,
birds, frogs, ¢shes and insects (Fig. 1C, not all data shown).
The product of the CDV-3B gene has a predicted pI of 5.77,
in good agreement with the apparent pI of TPP36 (pI 5.6^5.7)
as shown in Fig. 1. In contrast, the predicted molecular weight
of the protein, 29.7 kDa, is considerably smaller than the ap-
parent molecular weight of TPP36. When the FLAG-tagged
CDV-3B cDNA was expressed in 63-12 cells, the gene product
was detected by anti-FLAG antibody as a protein with ap-
parent molecular weight of 37 kDa and was tyrosine-phos-
phorylated upon pervanadate/H2O2 stimulation, as was ob-
served for TPP36 (Fig. 2). These results strongly suggest
that the cloned cDNA corresponding to CDV-3B encodes
TPP36.
3.2. Ubiquitous expression of TPP36 and its isoform TPP32
In order to analyze endogenous TPP36, polyclonal anti-
body against TPP36 was prepared by immunizing rabbits
with recombinant TPP36. FLAG-tagged TPP36 transiently
expressed in Cos7 cells could be detected by this antibody
but not with the pre-immune serum (Fig. 3A). Immunoblot
analysis of cell lysates from a panel of B lineage cell lines at
various developmental stages as well as normal tissues dem-
onstrated that the expression of TPP36 was not restricted to
the early stage of B cell development but rather that it was
ubiquitous (Fig. 3B,C). This is consistent with ubiquitous ex-
pression of CDV-3B mRNA reported by Fukumaru et al.
[22].
Besides TPP36, a smaller protein with an apparent molec-
ular weight of 32 kDa was detected by the anti-TPP36 anti-
body in all cell lines and tissues examined. Fukumaru et al.
have reported the cDNA clone CDV-3A, which is a splicing
variant of CDV-3B. CDV-3A was predicted to encode a
shorter protein of 236 amino acids in which the N-terminal
233 amino acids but not the C-terminal three amino acids
were identical to those predicted from the nucleotide sequence
of CDV-3B. A sequence analysis of the reverse-transcribed
PCR products prepared from the 63-12 proB cell line con-
¢rmed the existence of transcripts corresponding to CDV-
3A (data not shown). When the FLAG-tagged cDNA corre-
sponding to CDV-3A was transiently expressed in Cos7 cells,
the gene product was detected as a 33 kDa protein by anti-
FLAG or anti-TPP36 antibody (Fig. 4A). Therefore, the 32
kDa protein detected by anti-TPP36 antibody in cell lines and
normal tissues appeared to be encoded by the CDV-3A gene.
We designated this isoform of TPP36 protein TPP32. TPP36
and TPP32 share many features, such as the KKKKK motif,
the Gly/Ser-rich region, the Pro-rich region as well as the
position of the ¢rst three tyrosine residues. TPP36 has six
tyrosine residues while TPP32 has four. TPP32 was found
to be phosphorylated on tyrosine in 63-12 cells treated with
pervanadate/H2O2 as was TPP36 (Fig. 4B).
3.3. Cytoplasmic localization of TPP36/32
Analysis of the pSORT protein database by Reinhardt’s
method [23] predicted with 94.1% reliability that TPP36/32
are nuclear proteins, based on the presence in these proteins
of a cluster of basic amino acid residues including the repeat
of ¢ve lysine residues near the N-terminus, which may be a
potential nuclear localization signal. Therefore, we examined
the subcellular localization of TPP36 using confocal micros-
copy. When expressed in Cos7 or 293T cells, FLAG-tagged
TPP36 was detected by anti-FLAG antibody in cytoplasm but
not in nucleus (Fig. 5A, not all data shown). The presence of
Fig. 4. Characterization of TPP32. A: Cos7 cells were transiently
transfected with FLAG-TPP36 (CDV-3B) cDNA, FLAG-TPP32
(CDV-3A) cDNA or control vector. FLAG-TPP36/32 proteins in
cell lysates prepared 48 h after transfection were immunoprecipi-
tated with anti-FLAG Ab, followed by immunoblot analysis with
anti-TPP36 antiserum or anti-FLAG Ab. B: 63-12 Cells were
treated with or without pervanadate/H2O2 at 37‡C for 5 min. Cell
lysates were prepared and incubated with anti-TPP36 antiserum,
and the immunoprecipitates were immunoblotted with 4G10 or anti-
TPP36 antiserum.
Fig. 5. Subcellular localization of TPP36/32. A: Cos7 cells transi-
ently transfected with FLAG-TPP36 cDNA were stained with anti-
FLAG antibody. B: ST2 stromal cells were stained with anti-TPP36
antiserum. The stained cells were analyzed with confocal microsco-
py.
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the FLAG tag at either the N- or C-terminus gave the same
results, and FLAG-tagged TPP32 was also shown to be cyto-
plasmic (data not shown). Furthermore, endogenous TPP36/
32 were also detected in the cytoplasm but not in the nucleus
using the anti-TPP36 antibody (Fig. 5B). Thus, TPP36/32
turned out to be not nuclear proteins.
3.4. TPP36/32 were tyrosine-phosphorylated by Abl
In contrast to the results in 63-12 cells, we did not detect
phosphorylation on tyrosine of either the endogenous TPP36/
32 or the FLAG-tagged protein in Cos7 or 293T cells in
response to treatment of these cells with pervanadate/H2O2
(data not shown). We next sought to identify the tyrosine
kinase responsible for phosphorylation of TPP36. FLAG-
tagged TPP36 was transiently co-expressed in 293T cells
with individual tyrosine kinases from a panel including
c-Src, a constitutively active form of Src (DA-Src), Lyn,
Syk, Btk and a constitutively active form of Abl (Bcr-Abl).
Several proteins were phosphorylated on tyrosine in cells
transfected with the genes encoding each kinase (Fig. 6A).
Among them, a 36 kDa protein was prominently phosphory-
lated in cells transfected with the gene encoding Bcr-Abl. Im-
munoprecipitation of lysates from such cells with the anti-
FLAG antibody, followed by immunoblot analysis with the
4G10 antibody, revealed that the 36 kDa protein strongly
phosphorylated by Bcr-Abl was indeed TPP36 (Fig. 6B).
STI-571, a speci¢c inhibitor of Abl kinase activity [24], almost
completely inhibited both the phosphorylation of TPP36 and
the autophosphorylation of Bcr-Abl. Neither the weak phos-
phorylation of TPP36 by the other kinases nor the autophos-
phorylation of these other kinases was signi¢cantly in£uenced
by STI-571 (Fig. 6B). In order to examine whether endoge-
nous TPP36 could also be phosphorylated on tyrosine by Abl,
an engineered BaF3 proB cell line was used in which expres-
sion of Bcr-Abl is induced by doxycycline. Addition of doxy-
cycline to the culture induced expression and autophosphor-
ylation of Bcr-Abl as well as phosphorylation of TPP36/32 on
tyrosine (Fig. 6C). STI-571 almost completely inhibited both
the phosphorylation of TPP36/32 and the autophosphoryla-
tion of Bcr-Abl.
3.5. Phosphorylation of tyrosine 120 induced the mobility shift
of TPP36
When FLAG-tagged TPP36 was co-expressed with Bcr-Abl
in 293T cells, two distinct bands of phosphoproteins with ap-
Fig. 6. TPP36/32 were tyrosine-phosphorylated by Bcr-Abl. A,B:
293T cells were co-transfected with cDNA expression vectors encod-
ing FLAG-TPP36 and one of tyrosine kinases as indicated. In panel
A, whole proteins in cell lysates prepared 48 h after transfection
were subjected to SDS^PAGE, followed by immunoblot analysis
with anti-phosphotyrosine Ab or anti-FLAG Ab. In panel B, 24 h
after transfection, 293T cells were incubated with or without 10 WM
STI-571 at 37‡C for 1 h. Cell lysates were prepared and incubated
with anti-FLAG Ab or Ab speci¢c to each kinase. The immunopre-
cipitates were subjected to SDS^PAGE, followed by immunoblot
analysis with 4G10 or anti-FLAG Ab. C: TonB.210.1 cells were
cultured at 37‡C for 1 h with or without 1 Wg/ml doxycyclin in the
presence or absence of 10 WM STI-571. Cell lysates were incubated
with anti-Abl Ab or anti-TPP36 antiserum, and the immunoprecipi-
tates were subjected to SDS^PAGE, followed by immunoblot analy-
sis with 4G10, anti-Abl Ab or anti-TPP36 antiserum.
Fig. 7. Phosphorylation of tyrosine 120 of TPP36 by Bcr-Abl leads
to mobility shift of TPP36 in SDS^PAGE. 293T cells were co-trans-
fected with cDNA expression vectors encoding Bcr-Abl and one of
FLAG-TPP36 YF mutants as indicated. FLAG-TPP36 proteins in
cell lysates prepared 48 h after transfection were immunoprecipi-
tated with anti-FLAG Ab and subjected to SDS^PAGE, followed
by immunoblot analysis with 4G10 or anti-FLAG Ab.
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parent molecular weights of 37 and 40 kDa were detected by
immunoprecipitation with anti-FLAG antibody followed by
immunoblot analysis with antibody 4G10 (Fig. 7, WT). Im-
munoblot analysis with the anti-FLAG antibody revealed that
the 40 kDa band represented a small fraction of FLAG-
tagged TPP36. We also detected phosphorylation of the 40
kDa protein in 63-12 cells treated with pervanadate/H2O2
(Figs. 2B and 4B). A possible explanation for the migration
of a fraction of FLAG-tagged TPP36 with an apparent mo-
lecular weight of 40 kDa is that the 40 kDa form contains an
additional phosphorylated tyrosine residue compared to the
37 kDa form. To examine this directly, we created a series of
TPP36 mutants with substitution of individual tyrosine resi-
dues with phenylalanine and co-expressed them with Bcr-Abl
in 293T cells. The substitution of the ¢rst two tyrosine resi-
dues (Y120 and Y192) abolished the appearance of the 40
kDa phosphoprotein, but preserved the 37 kDa phosphopro-
tein (Fig. 7, Mut 1). In contrast, substitution of the latter four
tyrosine residues did not abolish the presence of either the 37
or 40 kDa phosphoproteins (Fig. 7, Mut2), although the ex-
tent of their phosphorylation was much reduced compared to
wild-type proteins (WT). Single substitution of Y120, but not
Y192, abolished the appearance of the 40 kDa phosphopro-
tein (Fig. 7, Mut 3 versus 4), indicating that phosphorylation
of Y120 induced the apparent mobility shift of TPP36. The
mobility shift of TPP32 from 32 to 35 kDa was also induced
by phosphorylation of tyrosine 120 (Fig. 4B, second lane; not
all data shown).
4. Discussion
In this study, we have molecularly cloned and biochemically
characterized TPP36 and its isoform TPP32 as novel sub-
strates of Abl kinase. c-Abl is a multidomain non-receptor
tyrosine kinase that is ubiquitously expressed and highly con-
served in metazoan evolution [25,26]. Mutant forms of c-Abl
have been identi¢ed in murine, feline and human leukemias.
Whereas the activity of wild-type Abl is tightly regulated, the
Bcr-Abl fusion protein produced through chromosomal trans-
location and found in human leukemias shows constitutively
elevated kinase activity leading to cellular transformation
[27,28]. It has recently been shown that the N-terminal region
of c-Abl is responsible for autoinhibition of c-Abl kinase ac-
tivity, and that its loss renders c-Abl oncogenic and contrib-
utes to deregulation of Bcr-Abl [29]. Although the mechanism
of the transformation by Bcr-Abl and its viral homolog v-Abl
have been extensively characterized [30], the normal biological
function and signaling mechanism of c-Abl are less well-
understood.
The expression of TPP36/32 appears to be ubiquitous, and
the proteins appear to be well conserved between a wide vari-
ety of species from humans to insects, as is the case with
c-Abl. In transiently transfected 293T cells, TPP36/32 were
more extensively phosphorylated on tyrosine when co-ex-
pressed with Bcr-Abl than when co-expressed with the other
tyrosine kinases examined. Phosphorylation of endogenous
TPP36/32 was also detected in TonB.210.1 cells after induc-
tion of Bcr-Abl expression. Furthermore, the phosphorylation
of TPP36/32 on tyrosine that we observed in 293T and
TonB.210.1 cells was almost completely inhibited by STI-
571, a speci¢c inhibitor of Abl kinase activity. These results
indicate that TPP36/32 are substrates of Abl tyrosine kinase.
It remains to be determined whether the phosphorylation of
TPP36/32 on tyrosine is essential to their physiological func-
tion. In this regard, it is notable that the phosphorylation of
Y120, but not the other tyrosine residues, leads to an appar-
ent shift in the mobility of these proteins when analyzed by
SDS^PAGE. This suggests that the phosphorylation of Y120
induces conformational change of TPP36/32. One might hy-
pothesize that this phosphorylation-induced conformational
change could be involved in regulation of the function of these
proteins. Mice de¢cient for Abl showed poor viability and
reduction of B cell progenitors in bone marrow [10^12], while
the induced expression of Bcr-Abl in vivo led to the develop-
ment of reversible preB cell leukemia [31]. Therefore, it could
be possible that TPP36/32 are involved in proliferation and
di¡erentiation of B progenitor cells through phosphorylation
by Abl.
The N-terminal portion of TPP36/32 is very well conserved
between di¡erent species and contains a cluster of basic amino
acid residues that is predicted with high likelihood to be a
nuclear localization signal. However, we detected both endog-
enous and exogenously expressed TPP36/32 predominantly in
the cytoplasm. To explore the possibility that the nuclear lo-
calization signal near the N-terminus of the protein might be
masked by other parts of TPP36, the N-terminal 30 amino
acids of TPP36/32 including the possible nuclear localization
signal were fused to the N-terminus of GFP, and the fusion
protein (N30-GFP) was expressed in Cos7 cells. N30-GFP
was detected both in the cytoplasm and the nucleus (data
not shown). Therefore, it was not conclusive as to whether
the putative nuclear localization signal near the N-terminus
was functional. In addition, we cannot formally exclude the
possibility that other proteins could bind and mask a nuclear
localization signal within TPP36/32. An intriguing question is
whether the putative conformational change induced by phos-
phorylation of Y120 could a¡ect the subcellular localization
of TPP36/32. Since the fraction of TPP36/32 phosphorylated
on Y120 is quite small, an antibody speci¢c to Y120-phos-
phorylated TPP36/32 is being prepared to enable study of its
subcellular localization.
Physiological functions of TPP36/32 remain to be deter-
mined. However, some clues exist to explore their functions.
The TPP36/32 gene expression is reportedly altered in certain
pathological conditions. The expression of the H41 gene, the
human homolog of the TPP36/CDV-3B gene, has been shown
to be up-regulated in malignant cancers of the breast and
ovary that are associated with the overexpression of the
HER-2/neu/c-erbB-2 proto-oncogene [32]. HER-2 encodes a
transmembrane receptor tyrosine kinase with extensive ho-
mology to epidermal growth factor (EGF) [33]. c-Abl is re-
portedly activated by growth factors such as EGF and PDGF
(platelet-derived growth factor) [34]. Therefore, TPP36 over-
expression and phosphorylation by Abl might be involved in
the pathogenic e¡ects of HER-2 overexpression in human
breast and ovarian cancers. Moreover, CDV-3B, which is
identical to the mouse TPP36 cDNA cloned in the present
study, has recently been reported to be a gene up-regulated
in the hypertrophied heart of juvenile visceral steatosis (JVS)
mice su¡ering from fatty liver, hyperammonemia, hypoglyce-
mia and growth retardation [22]. JVS mice exhibit carnitine
de¢ciency due to defective renal carnitine transport resulting
from a point mutation in the organic cation transporter 2
(OCTN2) gene [35]. It remains unclear whether TPP36/
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CDV-3B proteins are directly involved in the development of
cardiac hypertrophy. Since administration of carnitine signi¢-
cantly lowered levels of CDV-3B transcripts within 6 h, the
up-regulation of CDV-3B transcripts appeared to be linked to
an alteration in the metabolic state associated with carnitine
de¢ciency [22].
It seems too early to draw a whole picture of TPP36/32
integrating all the ¢ndings, namely the tyrosine phosphory-
lation of TPP36/32 by Abl, possible conformational change
of phosphorylated TPP36/32 and the up-regulation of the
TPP36/CDV-3B/H41 gene in hypertrophied heart of JVS
mice and human breast/ovarian cancers. The ubiquitous ex-
pression of TPP36/32 and their high conservation in evolution
might indicate their fundamental roles in vivo. In order to
know physiological functions of TPP36/32, we are currently
establishing mice de¢cient for TPP36/32.
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